Ubs Group Ag Stryker Corp Call Options Transaction History

Ubs Group Ag

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$315.94 - $371.96 $94,782 - $111,588	-300 Reduced 6.12%	4,600 $1.66 Million
Q2 2024 Aug 13, 2024	BUY	$324.3 - $354.67 $648,600 - $709,340	2,000 Added 68.97%	4,900 $1.67 Million
Q1 2024 May 13, 2024	BUY	$293.94 - $358.71 $852,426 - $1.04 Million	2,900 New	2,900 $1.04 Million
Q1 2023 May 12, 2023	BUY	$246.13 - $285.47 $6.65 Million - $7.71 Million	27,000 New	27,000 $7.71 Million
Q2 2020 Jul 31, 2020	SELL	$144.67 - $207.03 $96,639 - $138,296	-668 Reduced 44.53%	832 $150,000
Q3 2019 Nov 14, 2019	BUY	$205.4 - $221.82 $308,100 - $332,730	1,500 New	1,500 $324,000

2,228

285M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $146B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.